Anticoagulation and Antiplatelet Therapy Versus Anticoagulation Alone in Patients With Chronic Coronary Syndrome Receiving Long-Term Anticoagulation: A Meta-Analysis of Randomized Clinical Trials
Article Details
Authors (13)
Gilles Lemesle
Université de Lille, Institut Pasteur de Lille, INSERM Unité 1011, Lille, France
Romain Didier
Cardiology Department, CHU Brest, Brest, France
Abdourahmane Diallo
Unité de Recherche Clinique de l’Est Parisien (URCEST), Paris
Hubert Dromas
Heart and Lung Institute, University Hospital of Lille, CHU Lille, Lille, France (G.L., H.D., C.B., S.N.).
Christophe Bauters
Heart and Lung Institute, University Hospital of Lille, Centre Hospitalier Universitaire (CHU) Lille, Lille, France
Philippe Gabriel Steg
French Alliance for Cardiovascular Trials, Paris
Tabassome Simon
French Alliance for Cardiovascular Trials, Paris
Nicolas Danchin
French Alliance for Cardiovascular Trials, Paris
Sandro Ninni
Heart and Lung Institute, University Hospital of Lille, CHU Lille, Lille, France (G.L., H.D., C.B., S.N.).
Gilles Montalescot
Sorbonne Université, Paris
Eric Vicaut
Unité de Recherche Clinique de l’Est Parisien (URCEST), Paris
Martine Gilard
Cardiology Department, CHU Brest, Brest, France
Guillaume Cayla
Cardiology Department, Nimes University Hospital, Montpellier University, ACTION Study Group, Nimes, France